Guidewire Software Valuation
Is GWRE * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GWRE * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: GWRE * (MX$3768.76) is trading above our estimate of fair value (MX$2760.08)
Significantly Below Fair Value: GWRE * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GWRE *?
Key metric: As GWRE * is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is GWRE *'s PS Ratio? | |
|---|---|
| PS Ratio | 17.3x |
| Sales | US$980.50m |
| Market Cap | US$16.94b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 16.7x |
| Enterprise Value/EBITDA | -390.8x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does GWRE *'s PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 9.9x | ||
SGE Sage Group | 5.5x | 7.9% | UK£12.8b |
DOCU DocuSign | 5.9x | 6.1% | US$16.9b |
BSY Bentley Systems | 11.6x | 10.9% | US$15.3b |
MANH Manhattan Associates | 16.7x | 9.8% | US$17.1b |
GWRE * Guidewire Software | 17.3x | 12.7% | Mex$16.9b |
Price-To-Sales vs Peers: GWRE * is expensive based on its Price-To-Sales Ratio (17.3x) compared to the peer average (9.9x).
Price to Sales Ratio vs Industry
How does GWRE *'s PS Ratio compare vs other companies in the Global Software Industry?
| 243 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 243 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: GWRE * is expensive based on its Price-To-Sales Ratio (17.3x) compared to the Global Software industry average (3.1x).
Price to Sales Ratio vs Fair Ratio
What is GWRE *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 17.3x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate GWRE *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | Mex$3,956.12 0% | 16.2% | Mex$4,505.75 | Mex$2,560.09 | n/a | 13 |
| Nov ’25 | Mex$3,768.76 | Mex$3,813.75 +1.2% | 14.8% | Mex$4,359.47 | Mex$2,534.58 | n/a | 13 |
| Oct ’25 | n/a | Mex$3,349.96 0% | 13.4% | Mex$3,924.64 | Mex$2,217.42 | n/a | 14 |
| Sep ’25 | n/a | Mex$2,898.41 0% | 17.2% | Mex$3,470.72 | Mex$1,884.11 | n/a | 14 |
| Aug ’25 | Mex$2,728.81 | Mex$2,485.61 -8.9% | 14.8% | Mex$3,049.36 | Mex$1,704.05 | n/a | 14 |
| Jul ’25 | n/a | Mex$2,519.76 0% | 13.7% | Mex$3,129.97 | Mex$1,749.10 | n/a | 14 |
| Jun ’25 | n/a | Mex$2,143.68 0% | 12.9% | Mex$2,396.17 | Mex$1,359.53 | n/a | 14 |
| May ’25 | n/a | Mex$2,106.48 0% | 12.5% | Mex$2,351.40 | Mex$1,334.13 | n/a | 15 |
| Apr ’25 | n/a | Mex$2,106.48 0% | 12.5% | Mex$2,351.40 | Mex$1,334.13 | n/a | 15 |
| Mar ’25 | n/a | Mex$1,968.19 0% | 11.5% | Mex$2,242.03 | Mex$1,369.18 | n/a | 15 |
| Feb ’25 | n/a | Mex$1,961.79 0% | 11.0% | Mex$2,254.34 | Mex$1,376.70 | n/a | 15 |
| Jan ’25 | n/a | Mex$1,896.82 0% | 13.5% | Mex$2,246.98 | Mex$1,372.20 | n/a | 14 |
| Dec ’24 | n/a | Mex$1,746.45 0% | 13.9% | Mex$2,181.51 | Mex$1,194.64 | n/a | 14 |
| Nov ’24 | n/a | Mex$1,700.49 0% | 10.1% | Mex$1,979.11 | Mex$1,241.44 | Mex$3,768.76 | 14 |
| Oct ’24 | n/a | Mex$1,634.02 0% | 10.2% | Mex$1,903.47 | Mex$1,194.00 | n/a | 14 |
| Sep ’24 | n/a | Mex$1,473.72 0% | 8.1% | Mex$1,619.87 | Mex$1,176.54 | n/a | 14 |
| Aug ’24 | n/a | Mex$1,451.50 0% | 10.5% | Mex$1,622.27 | Mex$1,109.97 | Mex$2,728.81 | 14 |
| Jul ’24 | n/a | Mex$1,451.50 0% | 10.5% | Mex$1,622.27 | Mex$1,109.97 | n/a | 14 |
| Jun ’24 | n/a | Mex$1,473.33 0% | 12.2% | Mex$1,677.68 | Mex$1,059.59 | n/a | 14 |
| May ’24 | n/a | Mex$1,495.32 0% | 11.9% | Mex$1,708.57 | Mex$1,079.09 | n/a | 14 |
| Apr ’24 | n/a | Mex$1,495.32 0% | 11.9% | Mex$1,708.57 | Mex$1,079.09 | n/a | 14 |
| Mar ’24 | n/a | Mex$1,489.14 0% | 16.1% | Mex$1,788.32 | Mex$1,035.34 | n/a | 14 |
| Feb ’24 | Mex$1,503.72 | Mex$1,489.14 -1.0% | 16.1% | Mex$1,788.32 | Mex$1,035.34 | n/a | 14 |
| Jan ’24 | n/a | Mex$1,554.65 0% | 17.5% | Mex$1,963.13 | Mex$1,079.72 | n/a | 13 |
| Dec ’23 | n/a | Mex$1,580.35 0% | 16.3% | Mex$2,011.35 | Mex$1,149.34 | n/a | 13 |
| Nov ’23 | n/a | Mex$1,662.74 0% | 17.2% | Mex$2,094.00 | Mex$1,196.57 | n/a | 12 |
Analyst Forecast: Target price is lower than the current share price.